These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 183139)

  • 21. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of cellular immunity in the infection with herpes simplex virus.
    Kirchner H; Schröder CH; Zawatzky R; Kleinicke C
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):149-58. PubMed ID: 228888
    [No Abstract]   [Full Text] [Related]  

  • 23. Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.
    Kutinová L; Vonka V
    Infect Immun; 1978 Jun; 20(3):587-91. PubMed ID: 78899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells.
    Pfizenmaier K; Starzinski-Powitz A; Röllinghoff M; Falks D; Wagner H
    Nature; 1977 Feb; 265(5595):630-2. PubMed ID: 193023
    [No Abstract]   [Full Text] [Related]  

  • 25. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphology of central nervous system disease in immunosuppressed mice after peripheral herpes simplex virus inoculation. Trigeminal root entry zone.
    Townsend JJ; Baringer JR
    Lab Invest; 1979 Feb; 40(2):178-82. PubMed ID: 219289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.
    Ennis FA
    J Infect Dis; 1973 Jun; 127(6):632-8. PubMed ID: 4350518
    [No Abstract]   [Full Text] [Related]  

  • 28. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
    Plummer G
    Cancer Res; 1973 Jun; 33(6):1469-76. PubMed ID: 4352384
    [No Abstract]   [Full Text] [Related]  

  • 29. Demonstration of high levels of cytolytic antibodies reactive with HSV-1 and HSV-2 infected cell membranes in sera of genital tumour patients.
    Roane PR; washington P
    IARC Sci Publ (1971); 1975; (11 Pt 2):299-305. PubMed ID: 191374
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental immunosuppression induced by herpes simplex virus.
    Cappel R; Henry C; Thiry L
    Arch Virol; 1975; 49(1):67-72. PubMed ID: 172950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Fc receptors in herpes simplex virus infection.
    Costa JC; Rabson AS
    Lancet; 1975 Jan; 1(7898):77-8. PubMed ID: 46027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
    Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
    J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression.
    Cappel R; Gregoire F; Thiry L; Sprecher S
    J Clin Psychiatry; 1978 Mar; 39(3):266-8. PubMed ID: 204625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human ecto- and endocervical epithelial cells as targets for herpes simplex type two infection in vitro.
    Vesterinen E
    Acta Pathol Microbiol Scand B; 1976 Feb; 84(1):29-37. PubMed ID: 175640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo antibody-dependent cellular cytotoxicity of intravenous immunoglobulin G preparations against herpes simplex virus.
    Kohl S; Loo LS
    Rev Infect Dis; 1986; 8 Suppl 4():S446-8. PubMed ID: 3018896
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Status of antiviral immunity in patients with recurrent herpes].
    Semenova TB; Posevaia TA; Karpovich LG; Bukovskaia SN; Blokha VV
    Vestn Dermatol Venerol; 1987; (6):43-7. PubMed ID: 2820161
    [No Abstract]   [Full Text] [Related]  

  • 39. A detergent-soluble extract of virus-infected cells free from infectious virus protects mice from lethal herpes simplex virus infection.
    Ohashi Y; Sakaue Y; Kato S; Wada T; Sato K
    Biken J; 1980 Dec; 23(4):199-204. PubMed ID: 6266395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.